Sponsors / ZBIO
ZBIO

Zenas BioPharma (USA), LLC

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
6Trials in this database
10Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study of Obexelimab in Patients With IgG4-Related DiseaseNCT05662241Zenas BioPharma (USA), LLCPhase 3Active not recruiting2025-11-13Actual
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)NCT05786573Zenas BioPharma (USA), LLCPhase 3Active not recruiting2026-06-30Estimated
A Study of Obexelimab in Patients With Systemic Lupus ErythematosusNCT06559163Zenas BioPharma (USA), LLCPhase 2Active not recruiting2026-09Estimated
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)NCT06564311Zenas BioPharma (USA), LLCPhase 2Active not recruiting2025-08-28Actual
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisNCT07067463Zenas BioPharma (USA), LLCPhase 3Recruiting2030-06Estimated
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisNCT07299019Zenas BioPharma (USA), LLCPhase 3Recruiting2030-06Estimated

Latest recorded trial changes